VolitionRx Limited will attend the Citi 2016 Global Healthcare Conference on December 7-8 at The Lotte New York Palace in New York, NY, the company said on Thursday
Limited (NYSEMKT:VNRX) will attend the Citi 2016 Global Healthcare Conference on December 7-8 at The Lotte New York Palace in New York, NY, the company said on Thursday.
At the Citi Conference, Jake Micallef, Chief Scientific Officer of Volition, and Scott Powell, Vice President of Investor Relations, will provide an update on Volition's business, clinical, regulatory and operational milestones, as well as the Company's recently announced product launch of its Nu.QTM Colorectal Cancer Screening Triage Test.
VolitionRx shares were up 1% at $4.19 on Thursday.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of VolitionRx named herein, including the promotion by the Company of VolitionRx in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HERE